Six-year follow-up of phase II study exploring chemo-free treatment association with idelalisib and obinutuzumab in symptomatic relapsed/ refractory patients with Waldenström’s macroglobulinemia
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
No abstract available